Abstract. In human subjects cortisol raises the osmotic threshold for vasopressin release 
with the technical assistance of Rosemary Lewis Abstract. In human subjects cortisol raises the osmotic threshold for vasopressin release. The presumption that this results from a direct inhibitory action of cortisol on osmotically stimulated vasopressin release has been tested in conscious rhesus monkeys. Preparatory surgical procedures included chronic bladder catheterization, placement of cannulae in the right atrium, the left jugular vein and the stomach and stereotaxic insertion of metal cannulae in both supraoptic nuclei. The osmotic threshold for vasopressin release was defined as the plasma osmolality at the beginning of the 3 min urine sample in which free water clearance first fell by > 2 sd below the mean control level, in response to 5% saline infusion during constant hydration. Compared with control substances (0.9% saline solution or 11-deoxycortisol crystals), cortisol solution or crystals introduced into both supraoptic nuclei significantly lowered the plasma osmolality during the water-induced pre-saline diuresis, so that a larger amount of 5% NaCl infusion was required to reach the osmotic threshold. Thus, cortisol introduced into the supraoptic nuclei prolonged the duration of 5% saline infusion needed to reach the osmotic threshold, and raised the increment in plasma osmolality needed to reach the threshold but cortisol did not significantly raise the absolute level of the threshold.
It is well known that the excretion of an admini¬ stered water load is impaired in patients with adrenal insufficiency (Robinson et al. 1941) , can be restored to normal with cortisone (Dingman et al. 1957 ) and is further enhanced by pharmacological doses of glucocorticoids (Raisz et al. 1957 ). Cortisol has no antagonistic effect on the renal tubular action of circulating vasopressin (Kleeman et al. 1960; Lindeman et al. 1961 ) but a possible effect of cortisol on vasopressin release has remained controversial (Kleeman et al. 1958; Dingman 8c Despointes 1960). In 1965, work in our laboratory showed that an osmotic threshold could be defined at which vasopressin release was first stimulated by the rise in plasma osmolality induced by an infu¬ sion of hypertonic saline into normal human sub¬ jects (Aubry et al. 1965) . Further, cortisol admini¬ stration significantly raised the osmotic threshold by some mechanism other than antagonism of the effect of released vasopressin. Instead, we postu¬ lated that cortisol might inhibit osmoreceptor ini¬ tiation of vasopressin secretion (Aubry et al. 1965 ).
In In several experiments urinary vasopressin excretion was measured by radioimmunoassay immediately before and after the osmotic threshold for vasopressin release had been reached. Each specimen was acidified to pH 3-4 with acetic acid immediately after the osmolality measurements had been made, usually within 1 h of the completion of each experiment; and the specimens were then frozen for subsequent assay. ADH was extracted from each urine sample by means of the ion exchange resin CG-50 and quantitated by specific radioimmunoassay. This assay is specific for vasopressin and has no significant cross-reactivity with oxytocin. Recovery of vasopressin from urine by the CG-50 extraction proce¬ dure is 98.5 ± 9.5% (mean ± sd) and the coefficient of variation for the assay, including the variation due to the extraction procedure, is 16.8%. The minimum sensitivity of the assay was such as to allow the detection of vasopressin in the urine in concentrations of 1-2 (iU/ml , 1972 Fig. 1 ), as was to be expected since the 5% saline infusion had been given for 138 min before the threshold was reached, whereas it was infused for only 48 min before the threshold was reached in the control experiment (Fig. 1) .
Another experiment on the same monkey is shown in Fig. 3 (Fig. 5) starting 3 min before the hypertonic saline infusion was begun, an unfamiliar technician entered the room. The monkey's evident excitement was associated with a striking reduction in urine flow rate, a rise in urinary osmolality and a fall in free water clear¬ ance, during which measurable amounts of vaso¬ pressin appeared in the urine. As the excitement subsided, urine flow and free water clearance rose again, urinary osmolality fell and vasopressin dis¬ appeared from the urine. Vasopressin was still absent from the urine between 57 and 69 min after the start of the saline infusion. Large amounts of vasopressin were found in the urine sample voided during the 3 min period when the osmotic thresh¬ old was reached and in the following 3 min period before the experiment was terminated.
In a separate experiment (Fig. 6 ) performed on the same monkey, but after the introduction of cortisol crystals into both supraoptic nuclei, vaso¬ pressin was continuously absent from the urine from 60 to 105 min after the onset of the 5% saline infusion. However, 0.016 mU of vasopressin was found in the 3 min urine collected from 6 min after the attainment of the osmotic threshold for vaso¬ pressin release in this experiment.
Summary of osmotic threshold measurements in all experiments Table 1 shows the results obtained in 13 control experiments and 10 experiments after cortisol in¬ troduction into the supraoptic nuclei.
It is evident that the introduction of cortisol into the supraoptic nuclei had no significant effect on the absolute level of the osmotic threshold which was 301.8 ± 1.9 mOsm/kg in the control experi¬ ments and 301.7 ± 2.2 mOsm/kg in the cortisol experiments. There was, however, a highly signifi¬ cant increase in duration of the 5% saline infusion required to reach the osmotic threshold (104.1 ± 8.8 vs. 50.9 ±7.5 min, P< 0.001). In addition, introduction of cortisol into the supraoptic nuclei resulted in a significantly greater saline-induced change in plasma osmolality before the threshold was reached (23.1 ± 2.9 mOsm/kg) than when in¬ active substances were introduced into the supra¬ optic nuclei (10.2 ± 1.2 mOsm/kg, P < 0.001). Pretreatment with cortisol into the supraoptic nuclei caused a significant reduction in the plasma osmo¬ lality reached after similar degrees of water loading before the hypertonic saline was infused (279.3 ± 2.4 vs. 291.5 ± 1.6 mOsm/kg,P< 0.001).
The osmolality of individual 3 min urine samples usually remained strikingly constant during the diuresis which preceded and accompanied the ini¬ tiation of 5% saline infusion (Figs. 1-6 ). Mean urinary osmolality before saline infusion was un¬ affected by the previous introduction of cortisol into the supraoptic nuclei: control 59.5 ± 8.2 vs. 60.9 ± 6.2 mOsm/kg after cortisol. Mean urinary osmolality in the 3 min urines collected during the 15 min period immediately before the osmotic threshold was reached was slightly higher in the control experiments (78.6 ± 8.3 mOsm/kg) than in the experiments after the introduction of cortisol into the hypothalamic cannulae (51.7 ± 2.2 mOsm/kg, P < 0.02).
Post-mortem localization ofhypothalamic cannulae When the series of studies had been completed the monkeys were sacrificed and the location of the tips of the cannulae was verified by serial sections of the formalin-fixed brain. In the three animals used for these studies, the tips of the brain cannulae ended within or less than 1 mm from one or both supra¬ optic nuclei.
Discussion
The mechanism whereby cortisol raises the osmotic threshold for vasopressin release has not been investigated previously. The effect might be me¬ diated by an increase in plasma volume since ex¬ pansion of the circulating fluid volume by dextran infusions raises the osmotic threshold for vasopres¬ sin release (Moses et al. 1967) , while reduction of the effective plasma volume by dehydration (Miller 1975 (Miller , 1980 (Krieger et al. 1979; Miller 1980; Sabol 1978) . It should be pointed out that the difference between these findings in the monkey and the elevation of the absolute level of the osmotic threshold by cortisol in man (Aubry et al. 1965) might result in some way from the fact that the cortisol effect was confined to the supraoptic nuclei in the present experiments and was general¬ ized following the iv or oral administration of the steroid in the human studies.
The difference between the findings in the monkey and man might have resulted from cortisol-induced acceleration of excretion of the infused sodium chloride. This possibility is unlikely in view of the observation, in the experiments following cortisol administration, that urinary osmolality was equal to or lower (but not higher) than the levels found in the control experiments. Perhaps the cortisol accelerated transport or diffusion of so¬ dium out of the extracellular fluid into the cells so that the same water load produced (as was observed) a greater fall in plasma osmolality after the cortisol instillation than in its absence. If, in fact, cortisol did have one of these effects, then a larger amount of administered sodium would have been required after the cortisol to raise the plasma osmolality to the level of the osmotic threshold. Whatever the exact explanation might be, however, it is clear that minute amounts of cortisol acting on the supraoptic nuclei do increase the magnitude of the osmotic load needed to stimulate vasopressin release in the conscious rhesus monkey.
